Heart failure in outpatients. A randomized trial of digoxin versus placebo Academic Article uri icon

Overview

MeSH Major

  • Digoxin
  • Heart Failure

abstract

  • The view that digitalis clinically benefits patients with heart failure and sinus rhythm lacks support from a well-controlled study. Using a randomized, double-blind, crossover protocol, we compared the effects of oral digoxin and placebo on the clinical courses of 25 outpatients without atrial fibrillation. According to a clinicoradiographic scoring system, the severity of heart failure was reduced by digoxin in 14 patients; in nine of these 14, improvement was confirmed by repeated trials (five patients) or right-heart catheterization (four patients). The other 11 patients had no detectable improvement from digoxin. Patients who responded to digoxin had more chronic and more severe heart failure, greater left ventricular dilation and ejection-fraction depression, and a third heart sound. Multivariate analysis showed that the third heart sound was the strongest correlate of the response to digoxin (P less than 0.0001). These data suggest that long-term digoxin therapy is clinically beneficial in patients with heart failure unaccompanied by atrial fibrillation whose failure persists despite diuretic treatment and who have a third heart sound.

publication date

  • April 26, 1982

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 7038483

Additional Document Info

start page

  • 699

end page

  • 705

volume

  • 306

number

  • 12